LELAIS Gerald,LELAIS Gerald,EPPLE Robert,EPPLE Robert,MARSILJE III Thomas H.,MARSILJE III Thomas H.,MICHELLYS Pierre-Yves,MICHELLYS Pierre-Yves,MCNEILL Matthew H.,MCNEILL Matthew H.,LONG Yun,LONG Yun
申请号：
SI201330801
公开号：
SI2773635T1
申请日:
2013.06.05
申请国别(地区):
SI
年份:
2017
代理人:
摘要：
The invention provides compounds and pharmaceutical compositions thereof, which are useful for modulating EGFR activity, as well as methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated EGFR activity.
